TSC22D3 and colitis: As reported in Fig 2, two-way ANOVA (colitis x CORT treatment) showed a significant effect of colitis (F1,13 = 65.96, p<0.0001) and of CORT treatment (F1,13 = 147.6, p<0.0001) on colonic GILZ expression.